+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rheonix Inc - Product Pipeline Analysis, 2021 Update

  • PDF Icon

    Company Profile

  • 39 Pages
  • September 2021
  • GlobalData
  • ID: 5457493
Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products. The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied markets testing for food and beverage applications and next-generation sequencing sample preparation. Rheonix also develops Encompass workstation products such as Encompass MDx and Encompass Optimum. The company’s Encompass Optimum workstation provides information per sample for food and beverage testing. Rheonix is headquartered in Ithaca, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Rheonix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:


  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Rheonix Inc Company Overview
  • Rheonix Inc Company Snapshot
  • Rheonix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Rheonix Inc - Pipeline Analysis Overview
  • Rheonix Inc - Key Facts
  • Rheonix Inc - Major Products and Services
  • Rheonix Inc Pipeline Products by Development Stage
  • Rheonix Inc Pipeline Products Overview
  • Clopidogrel PGx Assay
  • Clopidogrel PGx Assay Product Overview
  • Encompass MDx System
  • Encompass MDx System Product Overview
  • GI CARD Assay
  • GI CARD Assay Product Overview
  • KRAS CARD Assay
  • KRAS CARD Assay Product Overview
  • Rheonix CARD - HIV Assay
  • Rheonix CARD - HIV Assay Product Overview
  • Rheonix CARD - Zika Virus Assay
  • Rheonix CARD - Zika Virus Assay Product Overview
  • Rheonix CARD HPV Assay
  • Rheonix CARD HPV Assay Product Overview
  • Rheonix SeptiCARD Device
  • Rheonix SeptiCARD Device Product Overview
  • Rheonix STI CARD Assay
  • Rheonix STI CARD Assay Product Overview
  • Rheonix STI Tri-Plex Assay
  • Rheonix STI Tri-Plex Assay Product Overview
  • Rheonix Swab Specimen Collection Kit
  • Rheonix Swab Specimen Collection Kit Product Overview
  • Rheonix Urine Specimen Collection Kit
  • Rheonix Urine Specimen Collection Kit Product Overview
  • UTI CARD Assay
  • UTI CARD Assay Product Overview
  • Warfarin PGx Assay
  • Warfarin PGx Assay Product Overview
  • Rheonix Inc - Key Competitors
  • Rheonix Inc - Key Employees
  • Rheonix Inc - Locations And Subsidiaries
  • Head Office

Recent Developments
Rheonix Inc, Recent Developments
  • Nov 19, 2019: Rheonix files 510(K) seeking FDA clearance of triplex sexually transmitted infection assay
  • Feb 22, 2018: NYU Researchers Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus
  • Apr 19, 2016: Rheonix To Pursue Rapid Zika Virus Diagnostic
  • Mar 10, 2016: Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing
  • Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental & Craniofacial Research of the National Institutes of Health
  • Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to Complete Development of a Rapid Point-of-Care Test for HIV/AIDS
  • Mar 24, 2014: Rheonix Invited to Present at 'The Future of In-Vitro Diagnostics' Conference hosted by Siemens
  • Jun 14, 2012: Rheonix Highlights First Fully Automated FFPE KRAS-Biomarker Assay At BIO International Convention
  • Dec 15, 2011: Rheonix Announces Novel Microarray Production Technology To Support Multiplexed Endpoint Detection Of SNPs On Rheonix CARD System
  • Nov 16, 2011: Rheonix Appoints Vice President Of Operations And Quality Manager

Appendix
  • Methodology
  • About the publisher
  • Contact the publisher
  • Disclaimer

List of Tables
  • Rheonix Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Rheonix Inc Pipeline Products by Equipment Type
  • Rheonix Inc Pipeline Products by Indication
  • Rheonix Inc, Key Facts
  • Rheonix Inc, Major Products and Services
  • Rheonix Inc Number of Pipeline Products by Development Stage
  • Rheonix Inc Pipeline Products Summary by Development Stage
  • Clopidogrel PGx Assay - Product Status
  • Clopidogrel PGx Assay - Product Description
  • Encompass MDx System - Product Status
  • Encompass MDx System - Product Description
  • GI CARD Assay - Product Status
  • GI CARD Assay - Product Description
  • KRAS CARD Assay - Product Status
  • KRAS CARD Assay - Product Description
  • Rheonix CARD - HIV Assay - Product Status
  • Rheonix CARD - HIV Assay - Product Description
  • Rheonix CARD - Zika Virus Assay - Product Status
  • Rheonix CARD - Zika Virus Assay - Product Description
  • Rheonix CARD HPV Assay - Product Status
  • Rheonix CARD HPV Assay - Product Description
  • Rheonix SeptiCARD Device - Product Status
  • Rheonix SeptiCARD Device - Product Description
  • Rheonix STI CARD Assay - Product Status
  • Rheonix STI CARD Assay - Product Description
  • Rheonix STI Tri-Plex Assay - Product Status
  • Rheonix STI Tri-Plex Assay - Product Description
  • Rheonix Swab Specimen Collection Kit - Product Status
  • Rheonix Swab Specimen Collection Kit - Product Description
  • Rheonix Urine Specimen Collection Kit - Product Status
  • Rheonix Urine Specimen Collection Kit - Product Description
  • UTI CARD Assay - Product Status
  • UTI CARD Assay - Product Description
  • Warfarin PGx Assay - Product Status
  • Warfarin PGx Assay - Product Description
  • Rheonix Inc, Key Employees
  • Glossary

List of Figures
  • Rheonix Inc Pipeline Products by Equipment Type
  • Rheonix Inc Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Moe Medical Devices, LLC
  • Innovative Medical Devices, Inc.
  • Diagnostic Devices Inc
  • Dexta Corp
  • Arista Biologicals Inc